Ocular surface disease management in cataract surgery
Archives of Clinical and Experimental Ophthalmology · 2025
DOI: 10.46439/ophthalmology.7.035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Clinical and Experimental Ophthalmology, 2025. Verfasst von Alessandro Mularoni und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Purpose
According to the literature, 80% of patients undergoing cataract surgery suffer from ocular surface disease (OSD). Along with postoperative refractive surprise, the onset of OSD is the main cause of dissatisfaction in cataract surgery patients, accounting for 35% of cases. These patients are characterized by persistent dysregulation of ocular surface para-inflammation, leading to chronic low- grade inflammation with significant consequences on daily activities and work productivity. This study aims to investigate the effects of topical desonide sodium phosphate 0.025% eye drops on the signs and symptoms of OSD in patients undergoing cataract surgery.
Methods
A multi center randomized controlled trial was conducted. Cataract patients without ocular comorbidities were consecutively enrolled and randomized into two groups. Both groups underwent phacoemulsification with standard postoperative therapy (levofloxacin 0.5% eye drops six times a day for 5 days and dexamethasone sodium phosphate 0.15% eye drops four times a day for 1 week and then twice a day for 1 week). Additionally, the study group received lubricating eye drops containing xanthan gum 0.2% and desonide sodium phosphate 0.025% three times a day, while the control group received hyaluronic acid 0.15% three times a day. At patient enrollment (T0), 1 day (T1), 2 weeks (T2), and 1 month after surgery (T3), signs and symptoms of OSD and tear function tests were recorded.
Results
OSDI scores significantly worsened at T1 in both groups (study: 28.4 ± 2.1 to 75.7 ± 5.7; control: 26.3 ± 1.8 to 68.0 ± 6.9; p
Zitieren
APA
Mularoni, A., Zazzo, A. D., Gaudenzi, D., Cutrupi, F., Gaudenzi, F., & Possati, G. L. (2025). Ocular surface disease management in cataract surgery. Archives of Clinical and Experimental Ophthalmology. https://doi.org/10.46439/ophthalmology.7.035
Vancouver
Mularoni A, Zazzo AD, Gaudenzi D, Cutrupi F, Gaudenzi F, Possati GL. Ocular surface disease management in cataract surgery. Archives of Clinical and Experimental Ophthalmology. 2025. doi:10.46439/ophthalmology.7.035
BibTeX
@article{Mularoni2025,
author = {Mularoni, Alessandro and Zazzo, Antonio Di and Gaudenzi, Daniele and Cutrupi, Francesco and Gaudenzi, Francesco and Possati, Giovanna Linda},
title = {Ocular surface disease management in cataract surgery},
journal = {Archives of Clinical and Experimental Ophthalmology},
year = {2025},
doi = {10.46439/ophthalmology.7.035}
}
EUVIMED